Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1Phase 1 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 3Gynecologic 1

Conditions

Carcinoma, Merkel Cell 2Uveal Melanoma 1Ovarian Neoplasms 1Melanoma 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interferon-beta × Clear all
NCT02584829 2022-03-22

Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
8 enrolled 16 charts
Dermatologic

Carcinoma, Merkel Cell

NCT02530047 2019-07-18

Mesenchymal Stem Cells (MSC) for Ovarian Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
5 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01758458 2017-04-19

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
4 enrolled
Dermatologic

Carcinoma, Merkel Cell

NCT00085306 2015-10-02

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

Case Comprehensive Cancer Center

Phase 2 Completed
21 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡